Amedisys (AMED) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Yahoo! Finance: AMED News
Enjoying Merger Arbitrage Limited?
Sign up then! It's quick and FREE
Have time to share an article? It's very much appreciated!!